loading...| Preferred Name |
Essential thrombocythemia |
|
| Synonyms |
Essential thrombocytosis |
|
| Definitions |
Essential thrombocythemia (ET) is a myeloproliferative neoplasm (MPN, see this term) characterized by a sustained elevation of platelet number (> 450 x 109/L) with a tendency for thrombosis and hemorrhage. |
|
| ID |
http://www.orpha.net/ORDO/Orphanet_3318 |
|
| alternative_term |
Essential thrombocytosis ET |
|
| definition |
Essential thrombocythemia (ET) is a myeloproliferative neoplasm (MPN, see this term) characterized by a sustained elevation of platelet number (> 450 x 109/L) with a tendency for thrombosis and hemorrhage. |
|
| definition_citation |
Orphanet |
|
| expertlink |
https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=3318 |
|
| has_age_of_onset |
All ages |
|
| has_inheritance |
Not applicable Multigenic/multifactorial |
|
| hasDbXref |
MedDRA:10015493 OMIM:187950 ICD-10:D47.3 OMIM:614521 ICD-11:3B63.1Z MeSH:D013920 OMIM:601977 UMLS:C0040028 |
|
| label |
Essential thrombocythemia |
|
| notation |
ORPHA:3318 |
|
| part_of | ||
| prefixIRI |
ORDO:Orphanet_3318 |
|
| prefLabel |
Essential thrombocythemia |
|
| present_in |
Sweden AND has_annual_incidence_average_value : 1.55 AND has_annual_incidence_range : 1-9 / 100 000 Sweden AND has_point_prevalence_average_value : 30.0 AND has_point_prevalence_range : 1-5 / 10 000 United States AND has_point_prevalence_average_value : 24.0 AND has_point_prevalence_range : 1-5 / 10 000 Europe AND has_point_prevalence_range : 1-5 / 10 000 Europe AND has_annual_incidence_average_value : 0.48 AND has_annual_incidence_range : 1-9 / 1 000 000 |
|
| treeView | ||
| subClassOf |